Recombinant proteins, peptides, and antibodies could account for up to half of all new drug approvals in coming years. Meanwhile, many of the original recombinant proteins are coming off patent or ...

The Recombinant Protein Production and Characterization (RPPC) Core is an Institutional Advanced Technology Core available to all Baylor College of Medicine investigators on a fee-for-service basis.

Protein characterization can be an extensive field of study covering a broad range of analytical methods and techniques. Although biochemists have made significant advances in protein analysis, the ...

Avenue Biosciences technology collects data sets on how specific signal peptides impact specific protein targets.

With complex biologics such as monoclonal antibodies (mAb), antibody-drug conjugates (ADCs) and cell and gene therapies (CGTs) attracting the attention of global big pharma companies, the scope of ...

Protein aggregation and active principle ingredients (API) stability are factors that ultimately impact both the usability and quality of many biopharmaceutical products, especially injectables. The ...

Collaboration combines Nuclera’s eProtein Discovery System, which accelerates protein expression, purification and optimization, with Cytiva’s Biacore SPR system, which characterizes molecular ...

When confirming antibody concentrations, sizing up proteins, or seeking the perfect formulation for a next-gen biologic, traditional approaches leave researchers tied to the lab bench for way too long ...

Approximately 25 percent of proteins localize to membranes, where they act as receptors and signaling molecules in biological processes, including respiration, neurotransmission, and molecular ...

Identification and overexpression of previously unknown genes associated with human disease is an important step toward developing new therapeutics. Current approaches rely on cloning and expressing ...